July Formulary Updates
Posted on June 29, 2017
Health New England’s formularies can be accessed on healthnewengland.org using the “Find A Drug” tool at the top of the page.
The online formularies are updated throughout the year as changes are made. We have three formularies, one for each line of business – Commercial, Medicare Advantage and Be Healthy/Medicaid. Each formulary includes the tier assignment for each drug and any drug-specific medication management requirements, including quantity limitations, step therapy requirements and prior authorization requirements.
Most recently, the following medications have been reviewed:
| Brand Name: Dupixent | Generic Name: Dupilumab |
| Brand Name: Erucrisa | Generic Name: Crisaborole |
| Brand Name: Emflaza | Generic Name: Deflazacort |
| Brand Name: Esbriet tablets | Generic Name: Pirfenidone |
| Brand Name: Pertzye | Generic Name: Pancrelipase |
| Brand Name: Synjardy XR | Generic Name: Empaglifozin/metformin |
No Comments
Share:
